Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OP-07 study for delayed methotrexate elimination during methotrexate-leucovorin rescue
jRCT2051220026Completed
- Sponsor
- Ohara Pharmaceutical Co., Ltd.
- Start
- Jul 2022
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of glucarpidase in Methotrexate overdose, sponsored by Ohara Pharmaceutical Co., Ltd. Primary endpoints: Adverse events and Blood methotrexate concentration 48 hours after the initial dose of OP-07. Started Jul 2022; status: completed.
02
Drugs
glucarpidase
03
Conditions
Methotrexate overdose
Beyond the preview
Go deeper on jRCT2051220026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051220026.